Patents by Inventor Julian Reading

Julian Reading has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250034139
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: October 4, 2024
    Publication date: January 30, 2025
    Inventors: David M. Simpson, Dennis Bryan Zerby, Ming LU, Reid Warren von Borstel, Rui Li, Julian Reading, Stephen Wolpe, Nureddin Aman
  • Patent number: 12139483
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Grant
    Filed: February 16, 2021
    Date of Patent: November 12, 2024
    Assignee: Pharma Cinq, LLC
    Inventors: David Michael Simpson, Dennis Bryan Zerby, Ming Lu, Reid Warren Von Borstel, Rui Li, Julian Reading, Stephen Wolpe
  • Publication number: 20210163476
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: February 16, 2021
    Publication date: June 3, 2021
    Inventors: David Michael SIMPSON, Dennis Bryan ZERBY, Ming LU, Reid Warren VON BORSTEL, Rui LI, Julian READING, Stephen WOLPE
  • Patent number: 10934284
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: March 2, 2021
    Assignee: Wellstat Therapeutics Corporation
    Inventors: David M. Simpson, Dennis Bryan Zerby, Ming Lu, Reid W. Von Borstel, Rui Li, Julian Reading, Stephen Wolpe
  • Publication number: 20190194193
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: February 26, 2019
    Publication date: June 27, 2019
    Inventors: David M. SIMPSON, Dennis Bryan ZERBY, Ming LU, Reid W. VON BORSTEL, Rui LI, Julian READING, Stephen WOLPE
  • Publication number: 20180298000
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 18, 2018
    Inventors: David M. SIMPSON, Dennis Bryan ZERBY, Ming LU, Reid W. VON BORSTEL, Rui LI, Julian READING, Stephen WOLPE, Nureddin AMAN
  • Patent number: 10030015
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: July 24, 2018
    Assignee: Wellstat Therapeutics Corporation
    Inventors: David M. Simpson, Dennis Bryan Zerby, Ming Lu, Reid W. von Borstel, Rui Li, Julian Reading, Stephen Wolpe, Nureddin Aman
  • Patent number: 9428552
    Abstract: Stem cells are mobilized from bone marrow by administering an amount of Phe-Pro-His-Phe-Asp-Leu-Ser-His-Gly-Ser-Ala-Gln-Val-Ser-Asp-Lys-Pro (SEQ ID NO: 2) or Phe-Ala-His-Phe-Asp-Leu-Ser-His-Gly-Ser-Ala-Gln-Val-Ser-Asp-Lys-Pro (SEQ ID NO: 3) effective to mobilize the stem cells. This is useful for promoting bodily tissue regeneration in a patient in need of tissue regeneration treatment. Alternatively, the mobilized stem cells can be collected for transplant.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: August 30, 2016
    Assignee: Wellstat Therapeutics Corporation
    Inventors: Irena Tsyrlova, Fawn Petty, Reid W. von Borstel, Julian Reading, Jiong Pei, Joel Saydoff
  • Publication number: 20160016997
    Abstract: Stem cells are mobilized from bone marrow by administering an amount of Phe-Pro-His-Phe-Asp-Leu-Ser-His-Gly-Ser-Ala-Gln-Val-Ser-Asp-Lys-Pro (SEQ ID NO: 2) or Phe-Ala-His-Phe-Asp-Leu-Ser-His-Gly-Ser-Ala-Gln-Val-Ser-Asp-Lys-Pro (SEQ ID NO: 3) effective to mobilize the stem cells. This is useful for promoting bodily tissue regeneration in a patient in need of tissue regeneration treatment. Alternatively, the mobilized stem cells can be collected for transplant.
    Type: Application
    Filed: November 18, 2013
    Publication date: January 21, 2016
    Inventors: Irena Tsyrlova, Fawn Petty, Reid W. von Borstel, Julian Reading, Jiong Pei, Joel Saydoff
  • Publication number: 20150361077
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: January 31, 2014
    Publication date: December 17, 2015
    Inventors: David M. Simpson, Dennis Bryan Zerby, Ming LU, Reid W. von Borstel, Rui Li, Julian Reading, Stephen Wolpe, Nureddin Aman
  • Publication number: 20140088006
    Abstract: Stem cells are mobilized from bone marrow by administering an amount of Phe-Pro-His-Phe-Asp-Leu-Ser-His-Gly-Ser-Ala-Gin-Val (SEQ ID NO: 1) effective to mobilize the stem cells. This method is useful for promoting preservation, repair, or regeneration of bodily tissue, or revascularization, in a patient in need of such treatment. Alternatively, the mobilized stem cells can be collected for transplant.
    Type: Application
    Filed: May 18, 2012
    Publication date: March 27, 2014
    Applicant: Wellstat Therapeutics Corporation
    Inventors: Irena Tsyrlova, Fawn Petty, Reid W. Von Borstel, Julian Reading